Home LiteratureArticle Details
PMID: 11890464 Published · ppublish English Journal Article Review

Safety assessment and public concerns for genetically modified food products: the Japanese experience.

Toxicologic pathology ·Vol. 30 ·No. 1 ·2002-00-00 ·Pages 126-8

Hino A

Abstract

The recombinant DNA (rDNA) technique is expected to bring about great progress in the improvement of breeding technology and the development of new plant varieties showing high quality and high yield, such as those with excellent pest and disease resistance, those with environmental stress tolerance, and so forth. In the United States and Canada, many genetically modified (GM) crop plants were commercialized as early as 1994. In Japan, 35 transgenic crop plants, such as herbicide tolerant soybean, cotton, and canola, and insect-resistant corn, cotton, and potatos, were authorized and considered marketable until April 2001. The general public, however, is not familiar with rDNA technology, and some people seem to feel uncomfortable with biotechnology, frequently because of the difficulty of the technology and lacking of sufficient information. New labeling systems were initiated in April 2001 in Japan to provide information regarding the use of GM crops as raw material.

MeSH Terms
Animals Food/toxicity Food Labeling Humans Japan Legislation, Food/trends Plants, Genetically Modified/genetics,toxicity Public Opinion
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Hino Akihiro
Gustatory Biology Laboratory, National Food Research Institute, Tsukuba, Ibaraki, Japan. [email protected]
Article Info
Journal
Toxicologic pathology
Abbr.
Toxicol Pathol
ISSN
0192-6233
Published
2002-00-00
Pages
126-8
Language
English
Region
United States
NLM ID
7905907
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]